IN8bio, Inc.
INAB
$1.75
-$0.03-1.69%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.66M | -23.89M | -27.43M | -30.44M | -31.88M |
| Total Depreciation and Amortization | 2.68M | 2.85M | 2.69M | 2.66M | 2.58M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.30M | 4.42M | 4.64M | 5.05M | 5.47M |
| Change in Net Operating Assets | 72.00K | -563.00K | 745.00K | -1.41M | -1.15M |
| Cash from Operations | -14.60M | -17.19M | -19.35M | -24.15M | -24.97M |
| Capital Expenditure | -33.00K | -33.00K | -116.00K | -187.00K | -226.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -33.00K | -33.00K | -116.00K | -187.00K | -226.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -801.00K | -891.00K | -831.00K | -794.00K | -748.00K |
| Issuance of Common Stock | 21.96M | 21.13M | 19.19M | 15.07M | 17.37M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 181.00K | 0.00 | 0.00 | -89.00K | -270.00K |
| Cash from Financing | 21.34M | 20.24M | 18.35M | 14.18M | 16.35M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.70M | 3.02M | -1.11M | -10.15M | -8.85M |